Natus Medical (BABY) Misses Q4 EPS by 2c

Natus Medical (NASDAQ: BABY) reported Q4 EPS of $0.51, $0.02 worse than the analyst estimate of $0.53. Revenue for the quarter came in at $107.7 million versus the consensus estimate of $107.58 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c